Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling

Saved in:
Bibliographic Details
Published in:Breast Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871928104736260097
collection WordPress RSS
FRELIP Feed Integration
container_title Breast Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:107076
institution FRELIP
journal_source_facet Breast Cancer : Targets and Therapy
last_indexed 2026-07-28T03:35:55.474Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
title_alt El miR-21 exosomal derivado de células de cáncer de mama resistentes al paclitaxel promueve la quimiorresistencia en el cáncer de mama a través de la señalización p53/PI3K/AKT/mTOR
Le miR-21 exosomal dérivé des cellules cancéreuses du sein résistantes au paclitaxel favorise la chimiorésistance dans le cancer du sein via la signalisation p53/PI3K/AKT/mTOR
miR-21 Exossômico Derivado de Células de Câncer de Mama Resistentes ao Paclitaxel Promove Quimiorresistência no Câncer de Mama via Sinalização p53/PI3K/AKT/mTOR
title_auth Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
title_es_txt El miR-21 exosomal derivado de células de cáncer de mama resistentes al paclitaxel promueve la quimiorresistencia en el cáncer de mama a través de la señalización p53/PI3K/AKT/mTOR
title_fr_txt Le miR-21 exosomal dérivé des cellules cancéreuses du sein résistantes au paclitaxel favorise la chimiorésistance dans le cancer du sein via la signalisation p53/PI3K/AKT/mTOR
title_full Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
title_fullStr Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
title_full_unstemmed Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
title_pt_txt miR-21 Exossômico Derivado de Células de Câncer de Mama Resistentes ao Paclitaxel Promove Quimiorresistência no Câncer de Mama via Sinalização p53/PI3K/AKT/mTOR
title_short Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
title_sort exosomal mir-21 derived from paclitaxel-resistant breast cancer cells promotes chemoresistance in breast cancer via p53/pi3k/akt/mtor signaling
topic Oncology
General
Oncology
url https://www.dovepress.com/exosomal-mir-21-derived-from-paclitaxel-resistant-breast-cancer-cells--peer-reviewed-fulltext-article-BCTT